Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia

Leukemia. 2024 Dec;38(12):2573-2584. doi: 10.1038/s41375-024-02455-9. Epub 2024 Nov 2.

Abstract

The transcription factor MYB is frequently upregulated in T-cell acute lymphoblastic leukemia (T-ALL), a hematological malignancy originating from T-cell precursors. Here, we demonstrate that MYB plays a crucial role by regulating genes essential for T-ALL pathogenesis. Integrative analysis reveals a long MYB isoform, ENST00000367814.8, which is dominantly expressed and confers a proliferative advantage in T-ALL cells. Rapid depletion of MYB via dTAG-mediated protein degradation affects a large number of genes, which can be classified into early response or late response genes based on their kinetics. Early response genes include many genes involved in hematopoiesis, such as TAL1, RUNX1, GATA3, IKZF2, and CXCR4. Their expression can be recovered at later time-points, suggesting the presence of a negative feedback loop mechanism. In contrast, late response genes, which are continuously downregulated after MYB depletion, includes many genes involved in cell proliferation as well as TAL1 targets, thereby affecting the cellular phenotype.

MeSH terms

  • Cell Proliferation / genetics
  • Gene Expression Regulation, Leukemic*
  • Humans
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / pathology
  • Proto-Oncogene Proteins c-myb* / genetics
  • Proto-Oncogene Proteins c-myb* / metabolism
  • Transcription, Genetic

Substances

  • Proto-Oncogene Proteins c-myb
  • MYB protein, human